The global bovine blood plasma derivatives market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 3.2 billion by 2030. The growth of this market is driven by the increasing demand for bovine blood plasma derivatives in biotechnology, pharmaceutical, cosmetic and food applications. Immunoglobulin segment accounted for the largest share of the global bovine blood plasma derivatives market in 2017 and is expected to continue its dominance throughout the forecast period due to its wide range of applications such as treatment for autoimmune disorders, prevention and treatment of infections, cancer therapy and transplantation medicine. Fibrinogen segment accounted for second-largest share in 2017 due to its wide range of applications such as treatment for bleeding disorders, cardiovascular diseases and thrombosis management among others. New born calf serum segment accounted for third-largest share in 2017 due to its wide range of applications such as nutritional supplements among others. Bovine serum albumin segment accounted fourth-largest share in 2017 due to its wide range of application such as nutritional supplements among others.
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is driving the growth of the global Bovine Blood Plasma Derivatives market.
- Increasing demand for animal-free products in food and pharmaceutical industries is also driving the growth of the global Bovine Blood Plasma Derivatives market.
- Growing awareness about animal-free products among consumers is also driving the growth of this market globally.
- The increasing number of research and development activities in this field are also contributing to its growth.
Industry Growth Insights published a new data on “Bovine Blood Plasma Derivatives Market”. The research report is titled “Bovine Blood Plasma Derivatives Market research by Types (Immunoglobulin, Fibrinogen, New Born Calf Serum, Bovine Serum Albumin, Fetal Bovine Serum, Thrombin, Other), By Applications (Biotechnology, Pharmaceutical, Cosmetic, Food, Nutrition Supplements, Other), By Players/Companies LAMPIRE Biological Laboratories, Inc., Proliant Inc., Kraeber & Co GmbH, Sigma-Aldrich Co. (Merck KGaA), Auckland BioSciences Ltd., Rocky Mountain Biologicals Inc.., Lake Immunogenics, Inc., Bovogen Biologicals Pty Ltd., Thermo Fisher Scientific, Inc”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bovine Blood Plasma Derivatives Market Research Report
By Type
Immunoglobulin, Fibrinogen, New Born Calf Serum, Bovine Serum Albumin, Fetal Bovine Serum, Thrombin, Other
By Application
Biotechnology, Pharmaceutical, Cosmetic, Food, Nutrition Supplements, Other
By Companies
LAMPIRE Biological Laboratories, Inc., Proliant Inc., Kraeber & Co GmbH, Sigma-Aldrich Co. (Merck KGaA), Auckland BioSciences Ltd., Rocky Mountain Biologicals Inc.., Lake Immunogenics, Inc., Bovogen Biologicals Pty Ltd., Thermo Fisher Scientific, Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Bovine Blood Plasma Derivatives Market Report Segments:
The global Bovine Blood Plasma Derivatives market is segmented on the basis of:
Types
Immunoglobulin, Fibrinogen, New Born Calf Serum, Bovine Serum Albumin, Fetal Bovine Serum, Thrombin, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biotechnology, Pharmaceutical, Cosmetic, Food, Nutrition Supplements, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- LAMPIRE Biological Laboratories, Inc.
- Proliant Inc.
- Kraeber & Co GmbH
- Sigma-Aldrich Co. (Merck KGaA)
- Auckland BioSciences Ltd.
- Rocky Mountain Biologicals Inc..
- Lake Immunogenics, Inc.
- Bovogen Biologicals Pty Ltd.
- Thermo Fisher Scientific, Inc
Highlights of The Bovine Blood Plasma Derivatives Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunoglobulin
- Fibrinogen
- New Born Calf Serum
- Bovine Serum Albumin
- Fetal Bovine Serum
- Thrombin
- Other
- By Application:
- Biotechnology
- Pharmaceutical
- Cosmetic
- Food
- Nutrition Supplements
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bovine Blood Plasma Derivatives Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bovine blood plasma derivatives are a type of medication that is derived from the blood of cows. They are used to treat a variety of conditions, including stroke, heart attack, and kidney failure.
Some of the major players in the bovine blood plasma derivatives market are LAMPIRE Biological Laboratories, Inc., Proliant Inc., Kraeber & Co GmbH, Sigma-Aldrich Co. (Merck KGaA), Auckland BioSciences Ltd., Rocky Mountain Biologicals Inc.., Lake Immunogenics, Inc., Bovogen Biologicals Pty Ltd., Thermo Fisher Scientific, Inc.
The bovine blood plasma derivatives market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bovine Blood Plasma Derivatives Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bovine Blood Plasma Derivatives Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bovine Blood Plasma Derivatives Market - Supply Chain
4.5. Global Bovine Blood Plasma Derivatives Market Forecast
4.5.1. Bovine Blood Plasma Derivatives Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bovine Blood Plasma Derivatives Market Size (000 Units) and Y-o-Y Growth
4.5.3. Bovine Blood Plasma Derivatives Market Absolute $ Opportunity
5. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Type
5.3.1. Immunoglobulin
5.3.2. Fibrinogen
5.3.3. New Born Calf Serum
5.3.4. Bovine Serum Albumin
5.3.5. Fetal Bovine Serum
5.3.6. Thrombin
5.3.7. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Application
6.3.1. Biotechnology
6.3.2. Pharmaceutical
6.3.3. Cosmetic
6.3.4. Food
6.3.5. Nutrition Supplements
6.3.6. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Bovine Blood Plasma Derivatives Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Bovine Blood Plasma Derivatives Demand Share Forecast, 2019-2029
9. North America Bovine Blood Plasma Derivatives Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Application
9.4.1. Biotechnology
9.4.2. Pharmaceutical
9.4.3. Cosmetic
9.4.4. Food
9.4.5. Nutrition Supplements
9.4.6. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Type
9.7.1. Immunoglobulin
9.7.2. Fibrinogen
9.7.3. New Born Calf Serum
9.7.4. Bovine Serum Albumin
9.7.5. Fetal Bovine Serum
9.7.6. Thrombin
9.7.7. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Bovine Blood Plasma Derivatives Demand Share Forecast, 2019-2029
10. Latin America Bovine Blood Plasma Derivatives Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Application
10.4.1. Biotechnology
10.4.2. Pharmaceutical
10.4.3. Cosmetic
10.4.4. Food
10.4.5. Nutrition Supplements
10.4.6. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Type
10.7.1. Immunoglobulin
10.7.2. Fibrinogen
10.7.3. New Born Calf Serum
10.7.4. Bovine Serum Albumin
10.7.5. Fetal Bovine Serum
10.7.6. Thrombin
10.7.7. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Bovine Blood Plasma Derivatives Demand Share Forecast, 2019-2029
11. Europe Bovine Blood Plasma Derivatives Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Application
11.4.1. Biotechnology
11.4.2. Pharmaceutical
11.4.3. Cosmetic
11.4.4. Food
11.4.5. Nutrition Supplements
11.4.6. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Type
11.7.1. Immunoglobulin
11.7.2. Fibrinogen
11.7.3. New Born Calf Serum
11.7.4. Bovine Serum Albumin
11.7.5. Fetal Bovine Serum
11.7.6. Thrombin
11.7.7. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Bovine Blood Plasma Derivatives Demand Share, 2019-2029
12. Asia Pacific Bovine Blood Plasma Derivatives Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Application
12.4.1. Biotechnology
12.4.2. Pharmaceutical
12.4.3. Cosmetic
12.4.4. Food
12.4.5. Nutrition Supplements
12.4.6. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Type
12.7.1. Immunoglobulin
12.7.2. Fibrinogen
12.7.3. New Born Calf Serum
12.7.4. Bovine Serum Albumin
12.7.5. Fetal Bovine Serum
12.7.6. Thrombin
12.7.7. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Bovine Blood Plasma Derivatives Demand Share, 2019-2029
13. Middle East & Africa Bovine Blood Plasma Derivatives Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Application
13.4.1. Biotechnology
13.4.2. Pharmaceutical
13.4.3. Cosmetic
13.4.4. Food
13.4.5. Nutrition Supplements
13.4.6. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Bovine Blood Plasma Derivatives Market Size and Volume Forecast by Type
13.7.1. Immunoglobulin
13.7.2. Fibrinogen
13.7.3. New Born Calf Serum
13.7.4. Bovine Serum Albumin
13.7.5. Fetal Bovine Serum
13.7.6. Thrombin
13.7.7. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Bovine Blood Plasma Derivatives Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Bovine Blood Plasma Derivatives Market: Market Share Analysis
14.2. Bovine Blood Plasma Derivatives Distributors and Customers
14.3. Bovine Blood Plasma Derivatives Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. LAMPIRE Biological Laboratories, Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Proliant Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Kraeber & Co GmbH
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Sigma-Aldrich Co. (Merck KGaA)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Auckland BioSciences Ltd.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Rocky Mountain Biologicals Inc..
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Lake Immunogenics, Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bovogen Biologicals Pty Ltd.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Thermo Fisher Scientific, Inc
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
&nb